Cite
HARVARD Citation
Hamaya, T. et al. (n.d.). PD58-12 CROSS-REACTIVITY BETWEEN THE FIRST-LINE CHEMOTHERAPY AND SUBSEQUENT IMMUNOTHERAPY IN PATIENTS WITH UNRESECTABLE OR METASTATIC UROTHELIAL CARCINOMA. Journal of urology. pp. e1017-. [Online].